Загрузка...
Aromatase inhibitor use, side effects and discontinuation rates in gynecologic oncology patients
OBJECTIVE. Aromatase inhibitors (AI) are frequently prescribed in gynecologic oncology. We sought to define the frequency and duration of AI use, characterize AI side effects and determine the reasons for discontinuation in these patients. METHODS. Uterine and ovarian cancer patients with AI use for...
Сохранить в:
| Опубликовано в: : | Gynecol Oncol |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8036903/ https://ncbi.nlm.nih.gov/pubmed/32847676 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2020.08.015 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|